Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Hospitals & Self/Home Healthcare) - Global Forecast to 2028
The global digital diabetes management market is projected to reach USD 31.3 Billion by 2028 from an estimated USD 16.8 Billion in 2023, at a CAGR of 13.3% during the forecast period. The significance of developing and implementing better diabetes care solutions has increased due to the rising prevalence of diabetes. Additionally, technological development has made it feasible for the market to introduce highly adaptable solutions. Among the other key drivers of market growth are the rising adoption of cloud-based enterprise solutions and the rising use of connected devices and apps. But during the forecast period, factors like high device costs, a lack of reimbursement in developing countries, and a higher acceptance of standard and traditional diabetes management devices are anticipated to hinder the market growth.
“Smart glucose meters segment accounted for the largest share in the Digital Diabetes Management market.”
The devices segment is sub-segmented into smart insulin pens, smart insulin pumps/closed-loop systems, smart insulin patches, smart insulin pens, and CGM systems. In 2022, the market for digital diabetes management devices was dominated by the smart glucose meter segment, which held a 25.2% market share. The convenience for using smart glucose meters and their advantages in the early detection of hypo- and hyperglycemic diabetes are primarily responsible for the growth of this market. Other factors driving the growing popularity of this market segment include technological advancements like Bluetooth-enabled glucometers, all-in-one glucometers with analysis capabilities, and portable, pocket-size glucometers.
“Wearable devices segment to grow at the highest CAGR during the forecast period.”
Both handheld and wearable devices are the sub-segment of the device types that are taken into account in the digital diabetes management device market. In 2022, wearable technology accounted for 60.3% of the market for digital diabetes management devices. During the forecast period, this segment is anticipated to grow at the highest CAGR of 13.2%. The market for wearables is growing as a result of technological advancements, an increase in the adoption of smart insulin pumps and insulin patches, and an increase in the number of regulatory approvals for wearables.
“The Self/home healthcare segment accounted for the largest share of Digital Diabetes Management market in 2022”
In 2022, the self-/home healthcare segment held the largest market share for digital diabetes management. This is primarily attributed to the rising patient acceptance of home care as a result of growing awareness of digital platforms for managing diabetes. Patients who require continuous insulin therapy benefit most from self-administration. Inpatient treatment is very expensive for patients who require long-term therapy, and it also keeps them from going back to their daily routines.
“North America accounted for the largest share of the Digital Diabetes Management market in 2021”
North America held the largest market share in 2022 with a share of 41.4%, followed by Europe with a share of 29.0%. The growth of connected diabetes management devices, the rising popularity of diabetes and obesity management apps, the rising demand for technologically advanced solutions, the growing acceptance of digital diabetes solutions by payers, government initiatives to promote digital health, and increasing awareness of self-diabetes management in the region are the main factors driving North America to dominate the digital diabetes management market.
A breakdown of the primary participants (supply-side) for the Digital Diabetes Management market referred to for this report is provided below:
Research Coverage:
The market study covers the digital diabetes management market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product & service, by device type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall digital diabetes management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
“Smart glucose meters segment accounted for the largest share in the Digital Diabetes Management market.”
The devices segment is sub-segmented into smart insulin pens, smart insulin pumps/closed-loop systems, smart insulin patches, smart insulin pens, and CGM systems. In 2022, the market for digital diabetes management devices was dominated by the smart glucose meter segment, which held a 25.2% market share. The convenience for using smart glucose meters and their advantages in the early detection of hypo- and hyperglycemic diabetes are primarily responsible for the growth of this market. Other factors driving the growing popularity of this market segment include technological advancements like Bluetooth-enabled glucometers, all-in-one glucometers with analysis capabilities, and portable, pocket-size glucometers.
“Wearable devices segment to grow at the highest CAGR during the forecast period.”
Both handheld and wearable devices are the sub-segment of the device types that are taken into account in the digital diabetes management device market. In 2022, wearable technology accounted for 60.3% of the market for digital diabetes management devices. During the forecast period, this segment is anticipated to grow at the highest CAGR of 13.2%. The market for wearables is growing as a result of technological advancements, an increase in the adoption of smart insulin pumps and insulin patches, and an increase in the number of regulatory approvals for wearables.
“The Self/home healthcare segment accounted for the largest share of Digital Diabetes Management market in 2022”
In 2022, the self-/home healthcare segment held the largest market share for digital diabetes management. This is primarily attributed to the rising patient acceptance of home care as a result of growing awareness of digital platforms for managing diabetes. Patients who require continuous insulin therapy benefit most from self-administration. Inpatient treatment is very expensive for patients who require long-term therapy, and it also keeps them from going back to their daily routines.
“North America accounted for the largest share of the Digital Diabetes Management market in 2021”
North America held the largest market share in 2022 with a share of 41.4%, followed by Europe with a share of 29.0%. The growth of connected diabetes management devices, the rising popularity of diabetes and obesity management apps, the rising demand for technologically advanced solutions, the growing acceptance of digital diabetes solutions by payers, government initiatives to promote digital health, and increasing awareness of self-diabetes management in the region are the main factors driving North America to dominate the digital diabetes management market.
A breakdown of the primary participants (supply-side) for the Digital Diabetes Management market referred to for this report is provided below:
- By Company Type: Tier 1–46%, Tier 2–33%, and Tier 3–21%
- By Designation: C-level–43%, Director Level–35%, and Others–22%
- By Region: North America–34%, Europe–26%, Asia Pacific–19%, Latin America- 11%, and Middle East and Africa– 10%
Research Coverage:
The market study covers the digital diabetes management market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product & service, by device type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall digital diabetes management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
- Analysis of key drivers (Increasing Prevalence Of Diabetes, Technological Advancements and Growing Adoption Of Cloud-Based Enterprise Solutions For Diabetes Management), restraints (High Cost Of Devices And Lack Of Reimbursement In Developing Countries and Higher Acceptance Of Traditional Diabetes Management Devices), opportunities (Increasing Diabetes-Related Health Expenditure In Emerging Economies), and challenges (Low Penetration In Developing Economies and Lack Of Data Security) influencing the growth of the digital diabetes management market
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global digital diabetes management market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global digital diabetes management market
- Market Development: Comprehensive information on the lucrative emerging regions by product & services, device types, end users, and region
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global digital diabetes management market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global digital diabetes management market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 PRODUCT AND SERVICES
1.2.2 DEVICE TYPE
1.2.3 END USER
1.2.4 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 REFINEMENTS IN SEGMENTATION OF GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
1.7.2 UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS
1.7.3 UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS
1.7.4 ADDITION OF RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2022)
FIGURE 7 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT MARKET (2022)
FIGURE 8 SUPPLY-SIDE ANALYSIS: SMART GLUCOSE METERS MARKET (2022)
FIGURE 9 SUPPLY-SIDE ANALYSIS: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET (2022)
FIGURE 10 SUPPLY-SIDE ANALYSIS: SMART INSULIN PENS MARKET (2022)
FIGURE 11 SUPPLY-SIDE ANALYSIS: SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET (2022)
FIGURE 12 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT APPS MARKET (2022)
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR DIGITAL DIABETES MANAGEMENT MARKET (2023–2028)
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 15 TOP-DOWN APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 16 BOTTOM-UP APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 17 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET SIZING, BY DEVICE TYPE
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 18 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 IMPACT OF RECESSION
3 EXECUTIVE SUMMARY
FIGURE 19 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 20 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 21 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 22 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 23 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 24 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 DIGITAL DIABETES MANAGEMENT MARKET OVERVIEW
FIGURE 25 INCREASING PREVALENCE OF DIABETES AND GROWING DEMAND FOR DIGITAL SOLUTIONS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 26 DEVICES TO ACCOUNT FOR LARGEST SHARE OF ASIA PACIFIC MARKET
4.3 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 27 US TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 REGIONAL MIX: DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 28 NORTH AMERICAN MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 DIGITAL DIABETES MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING ECONOMIES, 2023 VS. 2028 (USD MILLION)
FIGURE 29 DEVELOPED ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 30 DIGITAL DIABETES MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of diabetes
TABLE 2 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2021 VS. 2045
5.2.1.2 Technological advancements
TABLE 3 PRODUCT LAUNCHES WITH NEW TECHNOLOGICAL ADVANCEMENTS
5.2.1.3 Growing adoption of cloud-based enterprise solutions for diabetes management
5.2.1.4 Advent of artificial intelligence in diabetes care devices
5.2.1.5 Increasing penetration of digital platforms and adoption of mobile apps for diabetes management
5.2.2 RESTRAINTS
5.2.2.1 High cost of devices and lack of reimbursement in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing diabetes-related health expenditure
5.2.4 CHALLENGES
5.2.4.1 Low adoption in developing economies
5.2.4.2 Data security
5.3 INDUSTRY TRENDS
5.3.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
TABLE 4 HYBRID CLOSED-LOOP SYSTEMS: LATEST EXAMPLES
5.3.2 GROWING NUMBER OF COLLABORATIONS BETWEEN STAKEHOLDERS
TABLE 5 RECENT COLLABORATIONS IN DIGITAL DIABETES MANAGEMENT MARKET
5.3.3 INCREASING DEMAND FOR FLASH GLUCOSE MONITORING (FGM) SYSTEMS
5.4 REGULATORY ANALYSIS
5.4.1 REGULATORY LANDSCAPE
5.4.1.1 North America
5.4.1.1.1 US
TABLE 6 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
FIGURE 31 FDA 510(K) APPROVAL PROCESS
5.4.1.1.2 Canada
TABLE 7 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.2 Europe
FIGURE 32 CE APPROVAL PROCESS FOR DIGITAL DIABETES MANAGEMENT SOLUTIONS
5.4.1.3 Asia Pacific
5.4.1.3.1 Australia
5.4.1.3.2 Japan
TABLE 8 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN
5.4.1.3.3 China
TABLE 9 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.3.4 India
5.4.1.4 Latin America
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 INDICATIVE LIST OF REGULATORY AUTHORITIES
5.5 ECOSYSTEM ANALYSIS
FIGURE 33 DIGITAL DIABETES MANAGEMENT MARKET: ECOSYSTEM ANALYSIS (2022)
5.6 VALUE CHAIN ANALYSIS
FIGURE 34 DIGITAL DIABETES MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS (2022)
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 DIGITAL DIABETES MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 INTENSITY OF COMPETITIVE RIVALRY
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 THREAT OF SUBSTITUTES
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR DIGITAL DIABETES MANAGEMENT
FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2014–MAY 2023)
5.8.2 TOP APPLICANTS (COMPANIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS
FIGURE 36 TOP APPLICANT COMPANIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2014–2023
5.8.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS
FIGURE 37 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2014–2023
5.9 PRICING ANALYSIS
5.9.1 KEY PLAYERS: AVERAGE SELLING PRICE, BY DEVICE
TABLE 12 AVERAGE SELLING PRICE, BY DEVICE, 2022
5.10 SUPPLY CHAIN ANALYSIS
FIGURE 38 DIGITAL DIABETES MANAGEMENT MARKET: STAKEHOLDERS IN SUPPLY CHAIN
5.11 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 13 DIGITAL DIABETES MANAGEMENT MARKET: LIST OF CONFERENCES AND EVENTS
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
5.12.2 BUYING CRITERIA
FIGURE 40 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 15 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
5.13 TECHNOLOGY ANALYSIS
5.14 REIMBURSEMENT SCENARIO
TABLE 16 DIGITAL DIABETES MANAGEMENT PRODUCTS: GLOBAL COVERAGE AND REIMBURSEMENT
5.15 TRADE ANALYSIS
TABLE 17 TOP EXPORTERS OF DIGITAL DIABETES MANAGEMENT DEVICES, BY COUNTRY (2022)
TABLE 18 TOP IMPORTERS OF DIGITAL DIABETES MANAGEMENT DEVICES, BY COUNTRY (2022)
6 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 19 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 DEVICES
TABLE 20 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 21 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (THOUSAND UNITS)
6.2.1 SMART GLUCOSE METERS
6.2.1.1 Reducing prices and technological innovations to drive growth
TABLE 23 KEY SMART GLUCOSE METERS OFFERED BY MARKET PLAYERS
TABLE 24 SMART GLUCOSE METERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 SMART GLUCOSE METERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
6.2.2.1 CGM segment to grow at highest CAGR during forecast period
TABLE 26 KEY CGM SYSTEMS OFFERED BY MARKET PLAYERS
TABLE 27 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3 SMART INSULIN PENS
6.2.3.1 Increasing demand for personalized/patient-centric devices without risk of needle-stick injuries to drive growth
TABLE 29 KEY SMART INSULIN PENS OFFERED BY MARKET PLAYERS
TABLE 30 SMART INSULIN PENS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 SMART INSULIN PENS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.4 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES
6.2.4.1 Benefits of smart insulin pumps and closed-loop systems to drive growth
TABLE 32 KEY SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES OFFERED BY MARKET PLAYERS
TABLE 33 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3 DIGITAL DIABETES MANAGEMENT APPS
TABLE 35 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 36 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 DIABETES AND BLOOD GLUCOSE TRACKING APPS
6.3.1.1 Growing adoption of connected devices to drive growth
TABLE 37 KEY DIABETES AND BLOOD GLUCOSE TRACKING APPS OFFERED BY MARKET PLAYERS
TABLE 38 DIABETES AND BLOOD GLUCOSE TRACKING APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 WEIGHT AND DIET MANAGEMENT APPS
6.3.2.1 Growing obese population and increasing need to prevent diabetes to drive growth
TABLE 39 KEY WEIGHT AND DIET MANAGEMENT APPS OFFERED BY MARKET PLAYERS
TABLE 40 WEIGHT AND DIET MANAGEMENT APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 DATA MANAGEMENT SOFTWARE AND PLATFORMS
6.4.1 GROWING DEMAND FOR DIABETES DATA MANAGEMENT TO DRIVE GROWTH
TABLE 41 KEY DATA MANAGEMENT SOFTWARE AND PLATFORMS OFFERED BY MARKET PLAYERS
TABLE 42 DATA MANAGEMENT SOFTWARE AND PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SERVICES
6.5.1 INCREASING ADOPTION OF REMOTE ONLINE COACHING SERVICES AMONG DIABETES PATIENTS TO DRIVE GROWTH
TABLE 43 KEY SERVICES OFFERED BY MARKET PLAYERS
TABLE 44 DIGITAL DIABETES MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 45 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
7.2 WEARABLE DEVICES
7.2.1 WEARABLE DEVICES TO DOMINATE DIGITAL DIABETES MANAGEMENT DEVICES MARKET DURING FORECAST PERIOD
TABLE 46 WEARABLE DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 HANDHELD DEVICES
7.3.1 INCREASING DEMAND FOR REMOTE MONITORING TO BOOST GROWTH
TABLE 47 HANDHELD DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER
8.1 INTRODUCTION
TABLE 48 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 SELF/HOME HEALTHCARE
8.2.1 HIGH COST OF INPATIENT CARE TO FUEL PREFERENCE FOR SELF/HOME CARE
TABLE 49 DIGITAL DIABETES MANAGEMENT MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 HOSPITALS AND SPECIALTY DIABETES CLINICS
8.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS TO BOOST GROWTH
TABLE 50 DIGITAL DIABETES MANAGEMENT MARKET FOR HOSPITALS AND SPECIALTY DIABETES CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 ACADEMIC AND RESEARCH INSTITUTES
8.4.1 PRODUCT INNOVATION FOR DIABETES MANAGEMENT TO DRIVE GROWTH
TABLE 51 DIGITAL DIABETES MANAGEMENT MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 41 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT
TABLE 52 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 42 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
TABLE 53 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 55 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 57 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 58 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 US
9.2.2.1 Increasing diabetes prevalence and high penetration of digital platforms to boost market
TABLE 59 US: MACROECONOMIC INDICATORS
TABLE 60 US: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 61 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 62 US: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 US: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Favorable reimbursement scenario to drive digital diabetes management adoption in Canada
TABLE 65 CANADA: MACROECONOMIC INDICATORS
TABLE 66 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 67 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 68 CANADA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 70 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
FIGURE 43 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
TABLE 71 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 75 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Germany to dominate European market over forecast period
TABLE 77 GERMANY: MACROECONOMIC INDICATORS
TABLE 78 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 79 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 80 GERMANY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 81 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 82 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Government initiatives to support market growth
TABLE 83 UK: MACROECONOMIC INDICATORS
TABLE 84 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 85 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 86 UK: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 87 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 88 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Affordability of healthcare to propel adoption of digital solutions
TABLE 89 FRANCE: MACROECONOMIC INDICATORS
TABLE 90 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 91 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 92 FRANCE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 93 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 94 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Rising diabetes prevalence to offer growth opportunities
TABLE 95 ITALY: MACROECONOMIC INDICATORS
TABLE 96 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 97 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 98 ITALY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 99 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 100 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Growing healthcare budget and efforts to boost local manufacturing of medical products
TABLE 101 SPAIN: MACROECONOMIC INDICATORS
TABLE 102 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 103 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 104 SPAIN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 107 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 108 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 109 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 44 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
TABLE 112 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 114 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 115 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 117 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 China to hold largest share of APAC market
TABLE 118 CHINA: MACROECONOMIC INDICATORS
TABLE 119 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 120 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 121 CHINA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 122 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 123 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 High acceptance of digital solutions for diabetes management to boost growth
TABLE 124 JAPAN: MACROECONOMIC INDICATORS
TABLE 125 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 126 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 127 JAPAN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Rising diabetes prevalence and focus on cost curtailment to favor adoption
TABLE 130 INDIA: MACROECONOMIC INDICATORS
TABLE 131 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 132 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 133 INDIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 Initiatives to help treat or manage diabetes-related problems to drive market growth
TABLE 136 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 137 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 138 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 139 AUSTRALIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Government initiatives for diabetes management to drive growth
TABLE 142 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 143 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 144 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 147 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 148 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 149 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 150 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 151 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 152 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 153 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 154 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 155 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.2 BRAZIL
9.5.2.1 High private healthcare expenditure and increasing geriatric population to drive market
TABLE 158 BRAZIL: MACROECONOMIC INDICATORS
TABLE 159 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 160 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 161 BRAZIL: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 163 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Growing obesity rate in Mexico to drive market
TABLE 164 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 165 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 166 MEXICO: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 169 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 170 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 171 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 SLOW DIGITIZATION OF HEALTH SYSTEMS IN AFRICAN COUNTRIES TO AFFECT GROWTH
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 174 AFRICA: MACROECONOMIC INDICATORS
TABLE 175 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 176 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 177 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN
FIGURE 45 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL DIABETES MANAGEMENT MARKET
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 46 REVENUE SHARE ANALYSIS OF KEY PLAYERS OPERATING IN DIGITAL DIABETES MANAGEMENT MARKET (2018–2022)
10.4 MARKET SHARE ANALYSIS
FIGURE 47 MARKET SHARE ANALYSIS: SMART GLUCOSE METERS MARKET (2022)
FIGURE 48 MARKET SHARE ANALYSIS: CONTINUOUS GLUCOSE MONITORING DEVICES MARKET (2022)
FIGURE 49 MARKET SHARE ANALYSIS: INSULIN PUMPS MARKET (2022)
FIGURE 50 MARKET SHARE ANALYSIS: SMART INSULIN PENS MARKET (2022)
FIGURE 51 MARKET SHARE ANALYSIS: DIABETES APPS MARKET (2022)
10.5 COMPANY EVALUATION MATRIX
FIGURE 52 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.6 EVALUATION MATRIX FOR START-UP/SME PLAYERS (2022)
FIGURE 53 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR START-UP/SME PLAYERS, 2022
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
10.7 COMPETITIVE BENCHMARKING
10.7.1 OVERALL FOOTPRINT OF COMPANIES
TABLE 180 OVERALL FOOTPRINT OF COMPANIES
TABLE 181 COMPANY FOOTPRINT: BY PRODUCT & SERVICE
TABLE 182 COMPANY FOOTPRINT: BY DEVICE TYPE
TABLE 183 COMPANY FOOTPRINT: BY END USER
TABLE 184 COMPANY FOOTPRINT: BY REGION
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 185 PRODUCT LAUNCHES
10.8.2 DEALS
TABLE 186 DEALS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 MEDTRONIC
TABLE 187 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT (2022)
11.1.2 F. HOFFMANN-LA ROCHE
TABLE 188 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
FIGURE 55 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
11.1.3 DEXCOM, INC.
TABLE 189 DEXCOM, INC.: BUSINESS OVERVIEW
FIGURE 56 DEXCOM, INC.: COMPANY SNAPSHOT (2022)
11.1.4 ASCENSIA DIABETES CARE HOLDINGS AG
TABLE 190 ASCENSIA DIABETES CARE HOLDINGS AG: BUSINESS OVERVIEW
11.1.5 ABBOTT LABORATORIES
TABLE 191 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 57 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
11.1.6 B. BRAUN MELSUNGEN AG
TABLE 192 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 58 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
11.1.7 TIDEPOOL
TABLE 193 TIDEPOOL: BUSINESS OVERVIEW
11.1.8 GLOOKO, INC.
TABLE 194 GLOOKO, INC.: BUSINESS OVERVIEW
11.1.9 LIFESCAN, INC.
TABLE 195 LIFESCAN, INC.: BUSINESS OVERVIEW
11.1.10 AGAMATRIX
TABLE 196 AGAMATRIX: BUSINESS OVERVIEW
11.1.11 TANDEM DIABETES CARE, INC.
TABLE 197 TANDEM DIABETES CARE, INC.: BUSINESS OVERVIEW
FIGURE 59 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2022)
11.1.12 INSULET CORPORATION
TABLE 198 INSULET CORPORATION: BUSINESS OVERVIEW
FIGURE 60 INSULET CORPORATION: COMPANY SNAPSHOT (2022)
11.1.13 DARIOHEALTH CORPORATION
TABLE 199 DARIOHEALTH CORPORATION: BUSINESS OVERVIEW
FIGURE 61 DARIOHEALTH CORPORATION: COMPANY SNAPSHOT (2022)
11.1.14 ONE DROP
TABLE 200 ONE DROP: BUSINESS OVERVIEW
11.1.15 YPSOMED HOLDING AG
TABLE 201 YPSOMED HOLDING AG: BUSINESS OVERVIEW
FIGURE 62 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 ARKRAY
11.2.2 DOTTLI
11.2.3 ACON LABORATORIES, INC.
11.2.4 CARE INNOVATIONS, LLC
11.2.5 HEALTH2SYNC
11.2.6 EMPERRA GMBH E-HEALTH TECHNOLOGIES
11.2.7 AZUMIO
11.2.8 DECIDE CLINICAL SOFTWARE GMBH
11.2.9 PENDIQ GMBH
11.2.10 BEATO
*Details on Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 PRODUCT AND SERVICES
1.2.2 DEVICE TYPE
1.2.3 END USER
1.2.4 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 REFINEMENTS IN SEGMENTATION OF GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
1.7.2 UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS
1.7.3 UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS
1.7.4 ADDITION OF RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2022)
FIGURE 7 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT MARKET (2022)
FIGURE 8 SUPPLY-SIDE ANALYSIS: SMART GLUCOSE METERS MARKET (2022)
FIGURE 9 SUPPLY-SIDE ANALYSIS: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET (2022)
FIGURE 10 SUPPLY-SIDE ANALYSIS: SMART INSULIN PENS MARKET (2022)
FIGURE 11 SUPPLY-SIDE ANALYSIS: SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET (2022)
FIGURE 12 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT APPS MARKET (2022)
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR DIGITAL DIABETES MANAGEMENT MARKET (2023–2028)
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 15 TOP-DOWN APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 16 BOTTOM-UP APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 17 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET SIZING, BY DEVICE TYPE
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 18 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 IMPACT OF RECESSION
3 EXECUTIVE SUMMARY
FIGURE 19 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 20 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 21 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 22 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 23 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 24 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 DIGITAL DIABETES MANAGEMENT MARKET OVERVIEW
FIGURE 25 INCREASING PREVALENCE OF DIABETES AND GROWING DEMAND FOR DIGITAL SOLUTIONS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 26 DEVICES TO ACCOUNT FOR LARGEST SHARE OF ASIA PACIFIC MARKET
4.3 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 27 US TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 REGIONAL MIX: DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 28 NORTH AMERICAN MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 DIGITAL DIABETES MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING ECONOMIES, 2023 VS. 2028 (USD MILLION)
FIGURE 29 DEVELOPED ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 30 DIGITAL DIABETES MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of diabetes
TABLE 2 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2021 VS. 2045
5.2.1.2 Technological advancements
TABLE 3 PRODUCT LAUNCHES WITH NEW TECHNOLOGICAL ADVANCEMENTS
5.2.1.3 Growing adoption of cloud-based enterprise solutions for diabetes management
5.2.1.4 Advent of artificial intelligence in diabetes care devices
5.2.1.5 Increasing penetration of digital platforms and adoption of mobile apps for diabetes management
5.2.2 RESTRAINTS
5.2.2.1 High cost of devices and lack of reimbursement in developing countries
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing diabetes-related health expenditure
5.2.4 CHALLENGES
5.2.4.1 Low adoption in developing economies
5.2.4.2 Data security
5.3 INDUSTRY TRENDS
5.3.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
TABLE 4 HYBRID CLOSED-LOOP SYSTEMS: LATEST EXAMPLES
5.3.2 GROWING NUMBER OF COLLABORATIONS BETWEEN STAKEHOLDERS
TABLE 5 RECENT COLLABORATIONS IN DIGITAL DIABETES MANAGEMENT MARKET
5.3.3 INCREASING DEMAND FOR FLASH GLUCOSE MONITORING (FGM) SYSTEMS
5.4 REGULATORY ANALYSIS
5.4.1 REGULATORY LANDSCAPE
5.4.1.1 North America
5.4.1.1.1 US
TABLE 6 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
FIGURE 31 FDA 510(K) APPROVAL PROCESS
5.4.1.1.2 Canada
TABLE 7 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.2 Europe
FIGURE 32 CE APPROVAL PROCESS FOR DIGITAL DIABETES MANAGEMENT SOLUTIONS
5.4.1.3 Asia Pacific
5.4.1.3.1 Australia
5.4.1.3.2 Japan
TABLE 8 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN
5.4.1.3.3 China
TABLE 9 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.3.4 India
5.4.1.4 Latin America
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 INDICATIVE LIST OF REGULATORY AUTHORITIES
5.5 ECOSYSTEM ANALYSIS
FIGURE 33 DIGITAL DIABETES MANAGEMENT MARKET: ECOSYSTEM ANALYSIS (2022)
5.6 VALUE CHAIN ANALYSIS
FIGURE 34 DIGITAL DIABETES MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS (2022)
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 DIGITAL DIABETES MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 INTENSITY OF COMPETITIVE RIVALRY
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 THREAT OF SUBSTITUTES
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR DIGITAL DIABETES MANAGEMENT
FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2014–MAY 2023)
5.8.2 TOP APPLICANTS (COMPANIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS
FIGURE 36 TOP APPLICANT COMPANIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2014–2023
5.8.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS
FIGURE 37 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2014–2023
5.9 PRICING ANALYSIS
5.9.1 KEY PLAYERS: AVERAGE SELLING PRICE, BY DEVICE
TABLE 12 AVERAGE SELLING PRICE, BY DEVICE, 2022
5.10 SUPPLY CHAIN ANALYSIS
FIGURE 38 DIGITAL DIABETES MANAGEMENT MARKET: STAKEHOLDERS IN SUPPLY CHAIN
5.11 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 13 DIGITAL DIABETES MANAGEMENT MARKET: LIST OF CONFERENCES AND EVENTS
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
5.12.2 BUYING CRITERIA
FIGURE 40 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 15 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
5.13 TECHNOLOGY ANALYSIS
5.14 REIMBURSEMENT SCENARIO
TABLE 16 DIGITAL DIABETES MANAGEMENT PRODUCTS: GLOBAL COVERAGE AND REIMBURSEMENT
5.15 TRADE ANALYSIS
TABLE 17 TOP EXPORTERS OF DIGITAL DIABETES MANAGEMENT DEVICES, BY COUNTRY (2022)
TABLE 18 TOP IMPORTERS OF DIGITAL DIABETES MANAGEMENT DEVICES, BY COUNTRY (2022)
6 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 19 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 DEVICES
TABLE 20 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 21 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (THOUSAND UNITS)
6.2.1 SMART GLUCOSE METERS
6.2.1.1 Reducing prices and technological innovations to drive growth
TABLE 23 KEY SMART GLUCOSE METERS OFFERED BY MARKET PLAYERS
TABLE 24 SMART GLUCOSE METERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 SMART GLUCOSE METERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
6.2.2.1 CGM segment to grow at highest CAGR during forecast period
TABLE 26 KEY CGM SYSTEMS OFFERED BY MARKET PLAYERS
TABLE 27 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.3 SMART INSULIN PENS
6.2.3.1 Increasing demand for personalized/patient-centric devices without risk of needle-stick injuries to drive growth
TABLE 29 KEY SMART INSULIN PENS OFFERED BY MARKET PLAYERS
TABLE 30 SMART INSULIN PENS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 SMART INSULIN PENS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.4 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES
6.2.4.1 Benefits of smart insulin pumps and closed-loop systems to drive growth
TABLE 32 KEY SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES OFFERED BY MARKET PLAYERS
TABLE 33 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3 DIGITAL DIABETES MANAGEMENT APPS
TABLE 35 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 36 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 DIABETES AND BLOOD GLUCOSE TRACKING APPS
6.3.1.1 Growing adoption of connected devices to drive growth
TABLE 37 KEY DIABETES AND BLOOD GLUCOSE TRACKING APPS OFFERED BY MARKET PLAYERS
TABLE 38 DIABETES AND BLOOD GLUCOSE TRACKING APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 WEIGHT AND DIET MANAGEMENT APPS
6.3.2.1 Growing obese population and increasing need to prevent diabetes to drive growth
TABLE 39 KEY WEIGHT AND DIET MANAGEMENT APPS OFFERED BY MARKET PLAYERS
TABLE 40 WEIGHT AND DIET MANAGEMENT APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 DATA MANAGEMENT SOFTWARE AND PLATFORMS
6.4.1 GROWING DEMAND FOR DIABETES DATA MANAGEMENT TO DRIVE GROWTH
TABLE 41 KEY DATA MANAGEMENT SOFTWARE AND PLATFORMS OFFERED BY MARKET PLAYERS
TABLE 42 DATA MANAGEMENT SOFTWARE AND PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SERVICES
6.5.1 INCREASING ADOPTION OF REMOTE ONLINE COACHING SERVICES AMONG DIABETES PATIENTS TO DRIVE GROWTH
TABLE 43 KEY SERVICES OFFERED BY MARKET PLAYERS
TABLE 44 DIGITAL DIABETES MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 45 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
7.2 WEARABLE DEVICES
7.2.1 WEARABLE DEVICES TO DOMINATE DIGITAL DIABETES MANAGEMENT DEVICES MARKET DURING FORECAST PERIOD
TABLE 46 WEARABLE DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 HANDHELD DEVICES
7.3.1 INCREASING DEMAND FOR REMOTE MONITORING TO BOOST GROWTH
TABLE 47 HANDHELD DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER
8.1 INTRODUCTION
TABLE 48 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 SELF/HOME HEALTHCARE
8.2.1 HIGH COST OF INPATIENT CARE TO FUEL PREFERENCE FOR SELF/HOME CARE
TABLE 49 DIGITAL DIABETES MANAGEMENT MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 HOSPITALS AND SPECIALTY DIABETES CLINICS
8.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS TO BOOST GROWTH
TABLE 50 DIGITAL DIABETES MANAGEMENT MARKET FOR HOSPITALS AND SPECIALTY DIABETES CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 ACADEMIC AND RESEARCH INSTITUTES
8.4.1 PRODUCT INNOVATION FOR DIABETES MANAGEMENT TO DRIVE GROWTH
TABLE 51 DIGITAL DIABETES MANAGEMENT MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 41 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT
TABLE 52 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 42 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
TABLE 53 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 55 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 57 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 58 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 US
9.2.2.1 Increasing diabetes prevalence and high penetration of digital platforms to boost market
TABLE 59 US: MACROECONOMIC INDICATORS
TABLE 60 US: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 61 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 62 US: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 US: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Favorable reimbursement scenario to drive digital diabetes management adoption in Canada
TABLE 65 CANADA: MACROECONOMIC INDICATORS
TABLE 66 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 67 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 68 CANADA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 70 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
FIGURE 43 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
TABLE 71 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 75 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Germany to dominate European market over forecast period
TABLE 77 GERMANY: MACROECONOMIC INDICATORS
TABLE 78 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 79 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 80 GERMANY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 81 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 82 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Government initiatives to support market growth
TABLE 83 UK: MACROECONOMIC INDICATORS
TABLE 84 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 85 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 86 UK: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 87 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 88 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Affordability of healthcare to propel adoption of digital solutions
TABLE 89 FRANCE: MACROECONOMIC INDICATORS
TABLE 90 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 91 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 92 FRANCE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 93 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 94 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Rising diabetes prevalence to offer growth opportunities
TABLE 95 ITALY: MACROECONOMIC INDICATORS
TABLE 96 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 97 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 98 ITALY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 99 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 100 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Growing healthcare budget and efforts to boost local manufacturing of medical products
TABLE 101 SPAIN: MACROECONOMIC INDICATORS
TABLE 102 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 103 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 104 SPAIN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 107 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 108 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 109 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 44 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
TABLE 112 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 114 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 115 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 117 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 China to hold largest share of APAC market
TABLE 118 CHINA: MACROECONOMIC INDICATORS
TABLE 119 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 120 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 121 CHINA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 122 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 123 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 High acceptance of digital solutions for diabetes management to boost growth
TABLE 124 JAPAN: MACROECONOMIC INDICATORS
TABLE 125 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 126 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 127 JAPAN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Rising diabetes prevalence and focus on cost curtailment to favor adoption
TABLE 130 INDIA: MACROECONOMIC INDICATORS
TABLE 131 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 132 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 133 INDIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 Initiatives to help treat or manage diabetes-related problems to drive market growth
TABLE 136 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 137 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 138 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 139 AUSTRALIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Government initiatives for diabetes management to drive growth
TABLE 142 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 143 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 144 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 147 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 148 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 149 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 150 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 151 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 152 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 153 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 154 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 155 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.2 BRAZIL
9.5.2.1 High private healthcare expenditure and increasing geriatric population to drive market
TABLE 158 BRAZIL: MACROECONOMIC INDICATORS
TABLE 159 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 160 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 161 BRAZIL: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 163 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Growing obesity rate in Mexico to drive market
TABLE 164 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 165 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 166 MEXICO: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 169 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 170 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 171 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 SLOW DIGITIZATION OF HEALTH SYSTEMS IN AFRICAN COUNTRIES TO AFFECT GROWTH
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 174 AFRICA: MACROECONOMIC INDICATORS
TABLE 175 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 176 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
TABLE 177 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN
FIGURE 45 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL DIABETES MANAGEMENT MARKET
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 46 REVENUE SHARE ANALYSIS OF KEY PLAYERS OPERATING IN DIGITAL DIABETES MANAGEMENT MARKET (2018–2022)
10.4 MARKET SHARE ANALYSIS
FIGURE 47 MARKET SHARE ANALYSIS: SMART GLUCOSE METERS MARKET (2022)
FIGURE 48 MARKET SHARE ANALYSIS: CONTINUOUS GLUCOSE MONITORING DEVICES MARKET (2022)
FIGURE 49 MARKET SHARE ANALYSIS: INSULIN PUMPS MARKET (2022)
FIGURE 50 MARKET SHARE ANALYSIS: SMART INSULIN PENS MARKET (2022)
FIGURE 51 MARKET SHARE ANALYSIS: DIABETES APPS MARKET (2022)
10.5 COMPANY EVALUATION MATRIX
FIGURE 52 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.6 EVALUATION MATRIX FOR START-UP/SME PLAYERS (2022)
FIGURE 53 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR START-UP/SME PLAYERS, 2022
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
10.7 COMPETITIVE BENCHMARKING
10.7.1 OVERALL FOOTPRINT OF COMPANIES
TABLE 180 OVERALL FOOTPRINT OF COMPANIES
TABLE 181 COMPANY FOOTPRINT: BY PRODUCT & SERVICE
TABLE 182 COMPANY FOOTPRINT: BY DEVICE TYPE
TABLE 183 COMPANY FOOTPRINT: BY END USER
TABLE 184 COMPANY FOOTPRINT: BY REGION
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 185 PRODUCT LAUNCHES
10.8.2 DEALS
TABLE 186 DEALS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 MEDTRONIC
TABLE 187 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT (2022)
11.1.2 F. HOFFMANN-LA ROCHE
TABLE 188 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
FIGURE 55 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
11.1.3 DEXCOM, INC.
TABLE 189 DEXCOM, INC.: BUSINESS OVERVIEW
FIGURE 56 DEXCOM, INC.: COMPANY SNAPSHOT (2022)
11.1.4 ASCENSIA DIABETES CARE HOLDINGS AG
TABLE 190 ASCENSIA DIABETES CARE HOLDINGS AG: BUSINESS OVERVIEW
11.1.5 ABBOTT LABORATORIES
TABLE 191 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 57 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
11.1.6 B. BRAUN MELSUNGEN AG
TABLE 192 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 58 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
11.1.7 TIDEPOOL
TABLE 193 TIDEPOOL: BUSINESS OVERVIEW
11.1.8 GLOOKO, INC.
TABLE 194 GLOOKO, INC.: BUSINESS OVERVIEW
11.1.9 LIFESCAN, INC.
TABLE 195 LIFESCAN, INC.: BUSINESS OVERVIEW
11.1.10 AGAMATRIX
TABLE 196 AGAMATRIX: BUSINESS OVERVIEW
11.1.11 TANDEM DIABETES CARE, INC.
TABLE 197 TANDEM DIABETES CARE, INC.: BUSINESS OVERVIEW
FIGURE 59 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2022)
11.1.12 INSULET CORPORATION
TABLE 198 INSULET CORPORATION: BUSINESS OVERVIEW
FIGURE 60 INSULET CORPORATION: COMPANY SNAPSHOT (2022)
11.1.13 DARIOHEALTH CORPORATION
TABLE 199 DARIOHEALTH CORPORATION: BUSINESS OVERVIEW
FIGURE 61 DARIOHEALTH CORPORATION: COMPANY SNAPSHOT (2022)
11.1.14 ONE DROP
TABLE 200 ONE DROP: BUSINESS OVERVIEW
11.1.15 YPSOMED HOLDING AG
TABLE 201 YPSOMED HOLDING AG: BUSINESS OVERVIEW
FIGURE 62 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 ARKRAY
11.2.2 DOTTLI
11.2.3 ACON LABORATORIES, INC.
11.2.4 CARE INNOVATIONS, LLC
11.2.5 HEALTH2SYNC
11.2.6 EMPERRA GMBH E-HEALTH TECHNOLOGIES
11.2.7 AZUMIO
11.2.8 DECIDE CLINICAL SOFTWARE GMBH
11.2.9 PENDIQ GMBH
11.2.10 BEATO
*Details on Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
